Brucellosis Treatment
For uncomplicated brucellosis, the optimal first-line treatment is doxycycline 100 mg twice daily orally for 6 weeks combined with streptomycin 15 mg/kg daily intramuscularly for 2-3 weeks, which achieves the lowest relapse rates. 1, 2
First-Line Treatment Regimens
Preferred Option: Doxycycline-Streptomycin
- Doxycycline 100 mg twice daily orally for 6 weeks PLUS streptomycin 15 mg/kg daily intramuscularly for 2-3 weeks 1, 2
- This combination demonstrates superior efficacy with the lowest relapse rates compared to all other regimens 2, 3
- Meta-analysis shows doxycycline-streptomycin is significantly better than doxycycline-rifampicin (OR = 3.17; 95% CI = 2.05-4.91) 3
Alternative First-Line Option: Doxycycline-Gentamicin
- Doxycycline 100 mg twice daily orally for 6 weeks PLUS gentamicin 5 mg/kg daily parenterally as a single dose for 7 days 1, 2
- The World Health Organization recommends this as first-line with comparable efficacy to doxycycline-streptomycin 1
- Gentamicin offers the advantage of wider availability and shorter duration of parenteral therapy (7 days vs 14-21 days) 1
- No significant difference in outcomes between gentamicin and streptomycin regimens (OR = 1.89; 95% CI = 0.81-4.39) 3
- Use weight-based dosing of 5 mg/kg daily; fixed 500 mg dosing is not recommended 1
Second-Choice Regimen: Doxycycline-Rifampicin
- Doxycycline 100 mg twice daily orally for 6 weeks PLUS rifampicin 600-900 mg daily as a single morning dose for 6 weeks 1, 2
- This all-oral regimen is more convenient but has higher relapse rates than aminoglycoside-containing regimens 2, 3
- Important caveat: In regions where tuberculosis is endemic, avoid rifampicin due to risk of promoting mycobacterial resistance 1, 2
Second-Line Treatment Options
Doxycycline-Trimethoprim-Sulfamethoxazole
- Doxycycline 100 mg twice daily PLUS trimethoprim-sulfamethoxazole 800+160 mg twice daily for 6 weeks 1
- The Centers for Disease Control and Prevention suggests this as a cost-effective alternative in resource-limited settings with response rates above 90% 1
- Comparable efficacy to doxycycline-rifampicin in systematic reviews 4, 3
Quinolone-Containing Regimens
- Ofloxacin or ciprofloxacin combined with doxycycline or rifampicin 1
- The European Centre for Disease Prevention and Control advises reserving these as second or third agents due to higher cost and antimicrobial resistance concerns 1
- Similar efficacy to doxycycline-rifampicin but with higher relapse rates 4, 3
Treatment Duration and Monitoring
Standard Duration
- 6 weeks is the standard treatment duration for uncomplicated brucellosis 1, 2
- Shorter durations (3-4 weeks) are inadequate and associated with unacceptably high relapse rates of 22% vs 4.8% 2, 4
Expected Outcomes
- Relapse rates range from 5-15% even with appropriate treatment 1, 2
- Relapses are usually mild and respond to retreatment with the same regimens 1, 2
- Clinical improvement should be evident within 7-14 days of treatment initiation 5
Special Populations
Children Under 8 Years Old
- Rifampicin 600-900 mg daily PLUS trimethoprim-sulfamethoxazole for 6 weeks 6, 4
- Alternative: Rifampicin for 6 weeks PLUS gentamicin 5-6 mg/kg/day for 5-7 days 6, 4
- Tetracyclines are contraindicated due to dental staining risk 6, 7
Pregnant Women
- Rifampicin 900 mg once daily for 6 weeks as monotherapy 6, 7
- Tetracyclines are contraindicated in pregnancy 6, 7
Complicated Brucellosis
Brucellar Spondylitis (Spinal Involvement)
- Extend treatment duration to 12 weeks (3 months) 2
- Aminoglycoside-containing regimens may be superior to rifampicin-containing regimens 2
- The Infectious Diseases Society of America recommends MRI to confirm spinal involvement before extending therapy 2
- Always assess for back pain in brucellosis patients, as it may indicate spondylitis requiring prolonged treatment 2
Brucellar Endocarditis
- High mortality complication requiring aggressive antimicrobial therapy 2
- Surgical intervention needed in most cases 2, 6
Other Focal Complications
- Neurobrucellosis, cerebral abscess, epidural abscess, or splenic abscess may require surgical intervention if antibiotic-resistant 6, 7
- Treatment duration typically extended to 12-24 weeks 2
Common Pitfalls to Avoid
Monotherapy
- Never use monotherapy for brucellosis 4
- Monotherapy has significantly higher relapse rates (13% vs 4.8% for combination therapy) 4
Inadequate Duration
- Do not shorten treatment below 6 weeks for uncomplicated cases 2, 4
- Short-term regimens (less than 4 weeks) have relapse rates of 22% vs 4.8% for standard duration 4